We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VPCBW
1476
CALL
DELISTED
VPC Impact Acquisition Holdings II Warrant
VPCBW
$3.03M 0.01%
300,000
CNQ icon
1477
Canadian Natural Resources
CNQ
$94.3B
$3.03M 0.01%
109,200
-200,600
-65% -$5.73M
NBTB icon
1478
NBT Bancorp
NBTB
$2.71B
$3.03M 0.01%
+69,768
New +$3.08M
CVS icon
1479
CALL
CVS Health
CVS
$139B
$3.03M 0.01%
+32,500
New +$3.14M
TBSAW
1480
CALL
DELISTED
TB SA Acquisition Corp Warrant
TBSAW
$3.03M 0.01%
299,995
ITQ
1481
DELISTED
Itiquira Acquisition Corp. Class A Ordinary Shares
ITQ
$3.03M 0.01%
299,810
-550,244
-65% -$5.51M
BNAIW
1482
CALL
Brand Engagement Network Warrant
BNAIW
$2.45M
$3.02M 0.01%
300,000
NCAC
1483
DELISTED
Newcourt Acquisition Corp Class A Ordinary Share
NCAC
$3.02M 0.01%
294,018
-541,775
-65% -$5.54M
CVLT icon
1484
Commault Systems
CVLT
$5.02B
$3.01M 0.01%
47,937
+10,745
+29% +$666K
WEL
1485
DELISTED
Integrated Wellness Acquisition Corp
WEL
$3M 0.01%
292,016
KNSW.WS
1486
CALL
DELISTED
KnightSwan Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
KNSW.WS
$2.99M 0.01%
289,924
RCAC
1487
DELISTED
Revelstone Capital Acquisition Corp. Class A Common Stock
RCAC
$2.98M 0.01%
297,143
BOOM icon
1488
DMC Global
BOOM
$110M
$2.97M 0.01%
153,008
+10,767
+8% +$199K
ORIA
1489
DELISTED
Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA
$2.97M 0.01%
295,886
COR icon
1490
Cencora
COR
$62.1B
$2.97M 0.01%
17,943
+11,843
+194% +$1.87M
DHR icon
1491
CALL
Danaher
DHR
$143B
$2.97M 0.01%
+12,634
New +$2.93M
ALKS icon
1492
Alkermes
ALKS
$8.38B
$2.96M 0.01%
+113,404
New +$2.71M
KBE icon
1493
State Street SPDR S&P Bank ETF
KBE
$1.65B
$2.95M 0.01%
65,323
+47,223
+261% +$2.22M
CECO icon
1494
Ceco Environmental
CECO
$3.91B
$2.94M 0.01%
252,138
-33,030
-12% -$374K
BKR icon
1495
Baker Hughes
BKR
$59B
$2.94M 0.01%
+99,682
New +$2.75M
HYG icon
1496
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$2.94M 0.01%
+39,877
New +$2.94M
AAC.WS
1497
CALL
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$2.92M 0.01%
290,205
-169,689
-37% -$33.3K
VSAC
1498
DELISTED
Vision Sensing Acquisition Corp. Class A Common Stock
VSAC
$2.92M 0.01%
281,806
INDIW
1499
CALL
DELISTED
indie Semiconductor, Inc. Warrant
INDIW
$2.91M 0.01%
500,000
MIR.WS
1500
CALL
DELISTED
Mirion Technologies, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MIR.WS
$2.91M 0.01%
440,000

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.